ALLMedicine™ Scabies Center
Research & Reviews 661 results
https://doi.org/10.1371/journal.pntd.0011207
PLoS Neglected Tropical Diseases; Lake SJ, Engelman D et. al.
Mar 18th, 2023 - Mass drug administration (MDA) based on two doses of ivermectin, one week apart, substantially reduces prevalence of both scabies and impetigo. The Regimens of Ivermectin for Scabies Elimination (RISE) trial assessed whether one-dose ivermectin-ba...
https://doi.org/10.1093/ced/llad104
Clinical and Experimental Dermatology; Ranjan E, Arora S et. al.
Mar 18th, 2023 - Scabies and Fairyfly: more than meets the eye.|2023|Ranjan E,Arora S,Radhakrishnan S,Rameshkumar A,|
https://www.mdedge.com/dermatology/article/261819/infectious-diseases/spinosad-new-kid-block-treating-scabies
Doug Brunk
Mar 15th, 2023 - HONOLULU – A new option for treating scabies, topical spinosad marks a significant development in the scabies treatment landscape, Anthony J. Mancini, MD, said during a presentation at the Hawaii Dermatology Seminar provided by MedscapeLIVE! In Ap.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987233
CMAJ : Canadian Medical Association Journal = Journal De ... Bourkas AN, Pope E
Mar 7th, 2023 - Oral ivermectin treatment for an infant with crusted scabies.|2023|Bourkas AN,Pope E,|therapeutic use,diagnosis,drug therapy,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987785
PLoS Neglected Tropical Diseases; Amoako YA, van Rietschoten LS et. al.
Feb 23rd, 2023 - Scabies commonly affects poor populations in low-middle-income countries. The WHO has advocated for country-driven and country-owned control strategies. Knowledge of context specific issues will be important for design and implementation of scabie...
Guidelines 2 results
https://doi.org/10.1111/j.1346-8138.2008.00491.x
The Journal of Dermatology; , Ishii N
Jun 27th, 2008 - The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. F...
https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
National Institutes of Health (NIH)
Ivermectin is a Food and Drug Administration (FDA)-approved antiparasitic drug used to treat several neglected tropical diseases, including onchocerciasis, helminthiases, and scabies.1 For these indications, ivermectin has been widely used and is ...
Drugs 46 results see all →
Clinicaltrials.gov 44 results
https://clinicaltrials.gov/ct2/show/NCT04332068
Jan 20th, 2023 - Scabies is a skin infestation caused by a mite called Sarcoptes scabiei. Scabies is characterised by a rash and severe itching, which is an allergic reaction to the eggs and feces the females deposit as they tunnel under the skin. Oral ivermectin ...
https://clinicaltrials.gov/ct2/show/NCT05689463
Jan 19th, 2023 - The aim of the study is to evaluate the prevalence of positive anti BP180 and/or anti BP230 serology in the serum of patients with chronic and diffuse pruritus for at least 1 month under immunotherapy and in the absence of obvious pruritic dermato...
https://clinicaltrials.gov/ct2/show/NCT05643820
Dec 9th, 2022 - In children, pediculosis is a common ectoparasitic infestation. Infestation of head lice (Pediculus humanus capitis) causes a variety of physical symptoms, including pruritus, excoriation, cervical lymphadenopathy, and conjunctivitis1. It also has...
https://clinicaltrials.gov/ct2/show/NCT05500326
Dec 1st, 2022 - Children aged 2 to <5years and weighing 10 to <15 kg with clinically diagnosed scabies infection in the participating sites in Laos PDR will be approached for recruitment into the study if eligible (see eligibility criteria) and allocated into one...
https://clinicaltrials.gov/ct2/show/NCT05117528
Nov 25th, 2022 - Type of study and design The study is a prospective, longitudinal (open) cohort study within households in Sukuta, The Gambia. Households will be recruited, and all available household members asked to participate. Households will be followed for ...
News 118 results
https://www.mdedge.com/dermatology/article/261819/infectious-diseases/spinosad-new-kid-block-treating-scabies
Doug Brunk
Mar 15th, 2023 - HONOLULU – A new option for treating scabies, topical spinosad marks a significant development in the scabies treatment landscape, Anthony J. Mancini, MD, said during a presentation at the Hawaii Dermatology Seminar provided by MedscapeLIVE! In Ap.
https://www.mdedge.com/dermatology/article/260668/business-medicine/loss-letters
Jeffrey Benabio, MD, MBA
Jan 18th, 2023 - My desk looks nothing like my grandfather’s. It stands about mid-abdomen high and has a small surface, perhaps just enough for the monitor and a mug.
https://www.mdedge.com/dermatology/article/256939/infectious-diseases/one-state-pandemic-tamped-down-lice-and-scabies-cases
Heidi Splete
Aug 10th, 2022 - The incidence of lice and scabies decreased significantly among children and adults in North Carolina during the confinement period of the COVID-19 pandemic, between March 2020 and February 2021, according to a report in Pediatric Dermatology. Whe.
https://www.medscape.com/viewarticle/979022
Aug 10th, 2022 - The incidence of lice and scabies decreased significantly among children and adults in North Carolina during the confinement period of the COVID-19 pandemic, between March 2020 and February 2021, according to a report in Pediatric Dermatology. Whe...
https://www.medscape.com/viewarticle/976183
Jun 24th, 2022 - MADRID — Experts in the field feel it, and evidence proves it: scabies (mange) has become a new "real-time" challenge for dermatologists, especially since the outbreak of the COVID-19 pandemic. Yolanda Gilaberte, MD, PhD, president-elect of the Sp...